nafazatrom has been researched along with maitotoxin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Judd, AM; Koike, K; Login, IS; MacLeod, RM; Yasumoto, T | 1 |
Ehreth, JT; Judd, AM; Login, IS; MacLeod, RM | 1 |
2 other study(ies) available for nafazatrom and maitotoxin
Article | Year |
---|---|
Maitotoxin, a calcium channel activator, increases prolactin release from rat pituitary tumor 7315a cells by a mechanism that may involve leukotriene production.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Calcium; Cell Line; Indomethacin; Ion Channels; Marine Toxins; Oxocins; Pituitary Neoplasms; Prolactin; Prostaglandins; Pyrazoles; Pyrazolones; Rats; SRS-A | 1986 |
Nafazatrom, an arachidonate metabolism inhibitor, decreases prolactin and GH release.
Topics: Animals; Female; Fibrinolytic Agents; Growth Hormone; In Vitro Techniques; Marine Toxins; Oxocins; Prolactin; Pyrazoles; Pyrazolones; Radioimmunoassay; Rats; Rats, Inbred Strains; Thyrotropin | 1986 |